In this study, several altered proteins are involved in the ECM-receptor interaction, such as collagen, thrombospondin (THBS), fibronectin, vitronectin, and von Willebrand Factor (vWF), all of which were increased in the plasma of CHD-PAH patients (Fig. S11). This evidence concerns the gene FN1 and coronary artery disorder.